SCHEMBL14217539

SCHEMBL14217539

N#Cc1c(NC(=O)c2ccc3c(c2)OCC3)sc2c1CCN(C(=O)OCCF)C2

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.62
MAPT P10636 7/20 0.62
SMN1; SMN2 Q16637 5/20 0.62
KDM4E B2RXH2 4/20 0.62
LMNA P02545 3/20 0.62
NPSR1 Q6W5P4 3/20 0.62
HSD17B10 Q99714 2/20 0.62
HPGD P15428 2/20 0.62
RXFP1 Q9HBX9 1/20 0.62
MEN1 O00255 9/20 0.54
KMT2A Q03164 9/20 0.54
TP53 P04637 1/20 0.54
TSHR P16473 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.49
GRM5 P41594 1/20 0.44
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
MITF O75030 1/20 0.44
POLB P06746 1/20 0.44
CASP6 P55212 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3922311 0.91 ALDH1A1 (0.67) ALDH1A1MAPTSMN1; SMN2KDM4ELMNA
SCHEMBL3928773 0.86 ALDH1A1 (0.66) ALDH1A1MAPTSMN1; SMN2KDM4ELMNA
SCHEMBL3420914 0.78 ALDH1A1 (0.62) ALDH1A1MAPTSMN1; SMN2KDM4ELMNA
SCHEMBL3421825 0.76 ALDH1A1 (0.77) ALDH1A1MAPTSMN1; SMN2KDM4ELMNA
SCHEMBL3420588 0.75 ALDH1A1 (0.66) ALDH1A1MAPTSMN1; SMN2KDM4ELMNA
SCHEMBL13337747 0.75 ALDH1A1 (0.63) ALDH1A1MAPTSMN1; SMN2KDM4ELMNA
SCHEMBL3418028 0.75 ALDH1A1 (0.78) ALDH1A1MAPTSMN1; SMN2KDM4ELMNA
SCHEMBL3929125 0.75 ALDH1A1 (0.54) ALDH1A1MAPTSMN1; SMN2KDM4ELMNA
SCHEMBL3422755 0.75 L3MBTL1 (0.62) ALDH1A1MAPTSMN1; SMN2KDM4ELMNA
SCHEMBL3421903 0.75 ALDH1A1 (0.62) ALDH1A1MAPTSMN1; SMN2KDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1756118-B1 TETRAHYDROPYRIDOTHIOPHENES FOR USE IN THE TREATMENT OF CANCER NYCOMED GMBH (DE) 2008-05-28 EP disclosed